The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist - Wikidata - awgldk - TriplyDB

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

http://www.wikidata.org/entity/Q24629716

about

Increased NMDA receptor inhibition at an increased Sevoflurane MAC Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-D-aspartate receptor subunit from human brain Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter Inhibition of rabies virus infection in cultured rat cortical neurons by an N-methyl-D-aspartate noncompetitive antagonist, MK-801 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs Chemical dissociation of human awareness: focus on non-competitive NMDA receptor antagonists Characterization of ionotropic glutamate receptors in human lymphocytes Production of leukotrienes in a model of focal cerebral ischaemia in the rat Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity Exon silencing by UAGG motifs in response to neuronal excitation Cloning, expression and modulation of a mouse NMDA receptor subunit Ionotropic glutamate receptors mediate inducible defense in the water flea Daphnia pulex Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits From single target to multitarget/network therapeutics in Alzheimer's therapy Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties NMDA receptor regulation of cell death in the rat olfactory bulb.The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.Determinants of novel object and location recognition during development.Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Effects of excitatory amino acid receptor antagonists on pulpal blood flow of the rat mandibular incisor.Neuroprotective effects of MK-801 on L-2-chloropropionic acid-induced neurotoxicity.Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system.Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors.A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis.Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels.Structure and synthesis of a potent glutamate receptor antagonist in wasp venom.Central mammalian neurons normally resistant to glutamate toxicity are made sensitive by elevated extracellular Ca2+: toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801 Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex.Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity S-Methadone augments R-methadone induced respiratory depression in the neonatal guinea pig.Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain Rapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma.Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury.Long-term D1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist.Interaction of the NMDA receptor noncompetitive antagonist MK-801 with model and native membranes.

P2860

Q21261956-4047DE8E-3E91-483D-AC28-34A6A27B1206 Q24309668-7C11E50D-5A80-4C0A-AFF8-0CBFF1D315EE Q24530210-7A2AAD87-1D2C-4747-85AA-9B0687D7F1B2 Q24555193-631A7BDF-696A-4410-BFCA-65DCCE8CBA90 Q24645307-45F8E704-9A7D-456A-9A6B-38A70A54F08D Q24649753-855E303B-10B0-4679-8B81-B85A0B5444D1 Q24680216-BA21DB07-A828-4DE7-9FDA-3F0BE7D39A91 Q28236984-A30756C7-8D28-4FE2-A3EC-B637F7BD5074 Q28258538-6F67CB6B-018E-4C43-9BB7-1543DC430A63 Q28343936-D3BBA7F8-D692-4265-AAD2-06E30BED7DC5 Q28345776-33429969-6B49-40F1-94DA-8A1311B815BC Q28394433-1A458EFA-D508-4BD4-ACFA-D6DF7ECD8532 Q28469128-486D86BD-1A55-4665-926D-9B81128F22C8 Q28505031-1D7A2C8C-984A-4BC6-94B6-4F55E1CADB70 Q28544892-9D31AAD8-14C7-4A5C-951A-C8FCA1665E5C Q28570536-618F9AD5-45CF-4DEB-A7AE-C5BEAEA9BC8A Q28658200-B55EEC10-AE95-4C0E-910F-D05FB4B2C178 Q28820763-82064FB7-5408-40B6-ACC9-A77F0FBB9B2B Q30307358-98CD654C-31A2-4FC4-A111-638181F69927 Q30358207-4F55AD45-5A5F-470F-9178-EFD007E066DD Q30379705-26AF7D68-02BF-402F-934E-D680D844D8C8 Q30426922-782012E5-E462-4079-B099-8A4EA643AF9F Q30473410-F2336B03-7833-48D3-8196-837E145C74BF Q31093386-1A1B6372-989F-44A2-9CCF-4781721E3794 Q31961890-5C813991-F557-4F41-BBD1-AF7F34080AF7 Q32063141-FC9FAFF4-86A0-4153-989A-374484B55195 Q33211908-681E0AE1-A991-467E-A40C-E00ACFF0C9C4 Q33506180-2EF74DB4-F4D4-464B-BAC3-B6F0324460CF Q33554934-0491158A-77C8-4792-8DDD-02651DDE6191 Q33586627-1FBCC2EA-589A-4BBF-B8B7-7769D0353287 Q33645648-98222CBB-3B18-41F1-BF6D-04CEB8B35301 Q33652653-2BB027D3-0CAA-4918-8050-FA368D3965CB Q33709279-81E3760D-714F-444F-9B68-0D0C13C7BD6F Q33716890-FCEFBC8D-5E78-4C1F-8B92-1C1870F83E3B Q33806539-5428F9E4-1998-4F34-BE24-420B779F263F Q33833341-B712CC00-F9C5-4093-8441-05703798EDE9 Q33926990-0C00B0ED-8199-4936-AFF0-071D6B4B6E39 Q33937321-E660515F-A005-4DE2-BA05-B33E6690FC59 Q33988204-890019BF-E2E8-43E3-AFCD-9AAC00CA626E Q34019068-6422C9EB-D5CB-41F2-B284-E6C7603B3C96

P2860

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

http://www.wikidata.org/entity/Q24629716

description

1986 nî lūn-bûn

@nan

1986 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1986 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

name

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@ast

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@en

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@nl

type

label

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@ast

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@en

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@nl

prefLabel

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@ast

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@en

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@nl

P1433

Q24629716-99552AE8-71C9-42F7-9D46-C2ED85A8836F

P1476

Q24629716-9A6423AA-5610-4365-A846-3AB05EC74520

P2093

Q24629716-1E856D09-1C9B-48BC-A95E-B8AE6B5A4FE0

Q24629716-561F689E-B72F-4C72-BBCB-D782FAFADC0D

Q24629716-6547A9F4-1806-4F0C-A5BD-A7E9383DE8F2

Q24629716-6773F047-1CA6-4143-8A73-2CADE1E59483

Q24629716-8C2BFE85-7F81-4DD6-9BF8-F4C68E21D3CA

Q24629716-C80106BE-1B65-4097-BC72-6C0F59154924

P2860

Q24629716-172AECFA-8B8F-4B85-81BD-D8EEF9F49DD3

Q24629716-1B96C377-F54F-45A6-863B-BEECB6202F04

Q24629716-21024D76-BA80-43BC-BB22-10F87419734A

Q24629716-302C5A8F-92C1-4277-9325-A5B20ABD4C95

Q24629716-369AAB23-7525-47DB-975B-D2682C47F112

Q24629716-39AEA676-C494-4BE6-AAAD-4F1E0EE6017B

Q24629716-3C7C6ABF-2BF3-45A9-81F5-4AAD77CD2E3A

Q24629716-46E284E7-E601-470D-B4AD-495C0AC9068E

Q24629716-474CDCBB-1BAF-41BC-8E32-5C79A49E4228

Q24629716-62C04B2C-1D5F-4C0E-9C3F-3EA4A2F3192F

P304

Q24629716-F45E9DB2-1278-4C76-A82C-A467E34F2A6D

P31

Q24629716-541D6C2F-2D30-4EC8-A6C3-9AC7FBE752EA

P3181

Q24629716-D950D9AD-1C4A-4229-80B4-A001DE7FB590

P356

Q24629716-1A9CD92E-9642-4E0A-A07D-22B8A83F1A03

P407

Q24629716-0F0840F4-0BD2-44B1-BDAB-97AB6A37CF2A

P433

Q24629716-7167B553-A66E-4AFF-B2F6-D2576C7D1B75

P478

Q24629716-F9406C1F-24D8-4B45-B784-EF2E8037EEA9

P577

Q24629716-632080C1-4C2A-48EB-B1C1-96C811B493F9

P5875

Q24629716-5CAE6D71-5FE4-48E2-8831-D968B23A2999

P698

Q24629716-30A75BD7-1230-461F-9014-272F6D7B6CEF

P932

Q24629716-6CEFEE8A-D9E2-4400-9FEE-8064CA75C937

P3181

P356

PNAS.83.18.7104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

@en

P2093

A R Knight

http://www.w3.org/2001/XMLSchema#string

E H Wong

http://www.w3.org/2001/XMLSchema#string

G N Woodruff

http://www.w3.org/2001/XMLSchema#string

J A Kemp

http://www.w3.org/2001/XMLSchema#string

L L Iversen

http://www.w3.org/2001/XMLSchema#string

T Priestley

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine

Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog

Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain.

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate.

Naloxone-inaccessible sigma receptor in rat central nervous system.

Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters.

P304

7104-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

692401

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.83.18.7104

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

1986-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19633017

http://www.w3.org/2001/XMLSchema#string

P698

3529096

http://www.w3.org/2001/XMLSchema#string

P932

386661

http://www.w3.org/2001/XMLSchema#string